sodium salicylate has been researched along with 3,7-dimethyl-1-propargylxanthine in 1 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (3,7-dimethyl-1-propargylxanthine) | Trials (3,7-dimethyl-1-propargylxanthine) | Recent Studies (post-2010) (3,7-dimethyl-1-propargylxanthine) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 202 | 1 | 23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cronstein, BN; Montesinos, MC; Weissmann, G | 1 |
1 other study(ies) available for sodium salicylate and 3,7-dimethyl-1-propargylxanthine
| Article | Year |
|---|---|
Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB.
Topics: Adenosine Deaminase; Animals; Aspirin; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Female; Glucocorticoids; Inflammation; Isoenzymes; Leukocytes; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; NF-kappa B; NF-kappa B p50 Subunit; Prostaglandin-Endoperoxide Synthases; Protein Precursors; Purinergic P1 Receptor Antagonists; Salicylates; Sodium Salicylate; Sulfasalazine; Theobromine | 1999 |